Phio Pharmaceuticals Corp... (PHIO)
1.41
-0.02 (-1.40%)
At close: Feb 28, 2025, 3:59 PM
1.42
0.71%
After-hours: Feb 28, 2025, 04:00 PM EST
Phio Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | n/a | n/a | n/a | n/a | 21K | 138K | 15K | 19K | 34K | 71K | 399K | 97K | n/a |
| Cost of Revenue | 6.33M | 193K | 192K | 183K | 4.3K | 4.33M | 5.37M | 5.42M | 6.92M | 5.68M | 17.65M | 12.97M | n/a |
| Gross Profit | -6.33M | -193K | -192K | -183K | 16.7K | -4.19M | -5.36M | -5.4M | -6.89M | -5.61M | -17.25M | -12.88M | n/a |
| Operating Income | -10.82M | -11.46M | -13.51M | -8.79M | -8.99M | -7.36M | -14.06M | -9.02M | -10.24M | -8.83M | -20.95M | -12.97M | -12.77M |
| Interest Income | n/a | n/a | n/a | 1.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -10.83M | -11.48M | -13.29M | -8.79M | -8.91M | -7.36M | -14.07M | -8.99M | -10.22M | -8.8M | -20.93M | -12.88M | -10.22M |
| Net Income | -10.83M | -11.3M | -13.21M | -8.79M | -8.84M | -7.36M | -12.45M | -8.99M | -10.22M | -8.8M | -20.93M | -12.88M | -10.22M |
| Selling & General & Admin | 4.29M | 4.45M | 4.63M | 4.36M | 4.71M | 3.18M | 4.01M | 3.62M | 3.35M | 3.22M | 3.7M | 2.62M | 6.15M |
| Research & Development | 6.33M | 7.01M | 8.89M | 4.43M | 4.3M | 4.33M | 5.37M | 5.42M | 6.92M | 5.68M | 17.65M | 10.45M | 6.62M |
| Other Expenses | -6.13M | -18K | 224K | -1K | 79K | 4K | 4.7M | 3.11M | 2.44M | 2.21M | 2.63M | n/a | n/a |
| Operating Expenses | 4.49M | 11.46M | 13.51M | 8.79M | 9.01M | 7.5M | 9.38M | 9.03M | 10.27M | 8.9M | 21.35M | 13.07M | 12.77M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 24K | 30K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 10.82M | 11.46M | 13.51M | 8.79M | 9.01M | 7.5M | 9.38M | 9.03M | 10.27M | 8.9M | 21.35M | 13.07M | 12.77M |
| Income Tax | n/a | -175K | -75K | -134.3K | -67K | 4K | -1.62M | -74K | -91K | -113K | n/a | -95K | -2.55M |
| Shares Outstanding (Basic) | 231K | 126.16K | 118.68K | 42.43K | 4.26K | 1.18K | 379.62 | 113.44 | 109.89 | 36.96 | 19.76 | 8.88 | 7.88 |
| Shares Outstanding (Diluted) | 231.51K | 126.16K | 118.68K | 42.43K | 4.26K | 1.18K | 379.62 | 113.44 | 109.89 | 36.96 | 19.76 | 8.88 | 7.88 |
| EPS (Basic) | -46.87 | -89.61 | -111.32 | -207.25 | -2.07K | -6.22K | -32.8K | -79.28K | -93.03K | -238.08K | -1.06M | -1.45M | -1.3M |
| EPS (Diluted) | -46.76 | -89.61 | -111.32 | -207.25 | -2.07K | -6.22K | -32.8K | -79.28K | -93.03K | -238.08K | -1.06M | -1.45M | -1.3M |
| EBITDA | -10.64M | -11.29M | -13.09M | -8.72M | -8.92M | -7.28M | -14M | -8.96M | -10.16M | -8.74M | -20.85M | -12.7M | -15.16M |
| Depreciation & Amortization | 184K | 193K | 192K | 183K | 67K | 81K | 70K | 53K | 77K | 87K | 99K | 147K | 163K |